(hereinafter referred to as “Haofan Bio”) is going to be listed on GEM, issuing 27 million shares and raising 1.145 billion yuan, which will be invested in Suzhou Haofan Bio’s 100kg/year peptide and protein reagent R&D and production and headquarters construction project (Phase I), annual production capacity of Ltd. 100kg/year peptide and protein reagent R&D...

Paxlovid is a 3CL protease inhibitor PF-07321332 (hereinafter referred to as “PF”) in combination with low-dose ritonavir (Ritonavir). 07321332 (hereinafter referred to as “PF”) and low-dose ritonavir (Ritonavir) of the compound, in a report released by CIMB on December 5, focusing on the synthesis of PF intermediates caronic anhydride, caronic anhydride is considered by the...